VAQTA (Hepatitis A Vaccine, Inactivated)
VAQTA is a vaccine indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior…
Vaccines Updated During January 2022, From Newest to Oldest
PedvaxHIB (Haemophilus B Conjugate Vaccine (Meningococcal Protein Conjugate))
Liquid PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age. Liquid PedvaxHIB will…
RECOMBIVAX HB (Hepatitis B Vaccine (Recombinant))
RECOMBIVAX HB [Hepatitis B Vaccine. Recombinant] is indicated for prevention of infection caused by all known subtypes of hepatitis B virus. RECOMBIVAX HB is approved for use in…
Janssen COVID-19 Vaccine (Ad26.COV2.S)
Janssen COVID-19 vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute…
Adacel TDaP (CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE…)
Adacel is a vaccine indicated for active booster immunization against tetanus, diphtheria and pertussis. Adacel is approved for use in individuals 10 through 64 years of age. Adacel is a…